Active Ingredient: SOTAGLIFLOZIN
Proprietary Name: INPEFA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216203
Product Number: 002
Approval Date: May 26, 2023
Applicant Holder Full Name: LEXICON PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
